Repurposing disulfiram as treatment for metastatic colorectal cancerAn investigator initiated clinical phase II trial
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Primary objective: Disease-control rate (complete response, partial response and/or stable disease >= 18 weeksTo investigate efficacy and safety of the treatment combination irinotecan, disulfiram and copper in patients with metastatic colorectal cancer having developed resistance to irinotecan. Primary objective: Disease-control rate (complete response, partial response and/or stable disease >= 18 weeks
创建时间：
2019-10-15
